Associations between genetic HPV 16 diversity and cervical cancer prognosis

Associations between genetic HPV 16 diversity and cervical cancer prognosis

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Patrícia Patury, Fabio B. Russomano, Miguel Angelo Martins Moreira, Nádia R. C. Kappaun, Liz Maria de Almeida, Raquel B. M. Carvalho, Luís Felipe. L. Martins
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12193069/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Associations between genetic HPV 16 diversity and cervical cancer prognosis.
by: Patrícia Patury, et al.
Published: (2025-01-01)

Genetic Diversity of HPV 16 and HPV 18 Based on Partial Long Control Region in Iranian Women
by: Mina Mobini Kesheh, et al.
Published: (2022-01-01)

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67.
by: Zigui Chen, et al.
Published: (2011-01-01)

Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis
by: Shrinka Sen, et al.
Published: (2017-04-01)

HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker
by: Jie Zhou, et al.
Published: (2025-07-01)

Immunohistochemical characteristic of expression levels of Kі-67, p16INK4a, HPV16 in cervical intraepithelial neoplasia and cervical cancer
by: V. A. Tumanskiy, et al.
Published: (2017-08-01)

HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series
by: Maria Gabriela Loffredo D’Ottaviano, et al.
Published: (2013-01-01)

A study on the correlation between HPV DNA and IHC P16 expression in cervical lesions
by: WANG Haochen, JIA Liqing, YANG Yu, WANG Qian, YU Chengli, TIAN Tian, BI Rui, TU Xiaoyu, BAI Qianming, ZHU Xiaoli, ZHOU Xiaoyan, REN Min
Published: (2025-03-01)

Analysis of HPV-16 viral load, integration status, and p16 expression in relation to EBV co-infection and cervical lesion severity
by: Azam Khamseh, et al.
Published: (2025-03-01)

The COPII Transport Complex Participates in HPV16 Infection
by: Patricia M. Day, et al.
Published: (2025-04-01)

Prevalence of HPV16 IgG Antibody and Rt-Pcr DNAdetection in Patients with Laryngeal Carcinoma and Cervical Dysplasia
by: Georgi Nikolov, et al.
Published: (2016-12-01)

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.
by: Shih-Wen Lin, et al.
Published: (2013-01-01)

Analysis of the differences between HPV-independent and HPV-related cervical adenocarcinoma
by: Jing He, et al.
Published: (2025-04-01)

The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers
by: Terkimbi Dominic Swase, et al.
Published: (2025-02-01)

Cervical cancer in India and HPV vaccination
by: K Kaarthigeyan
Published: (2012-01-01)

Corrigendum: Analysis of the differences between HPV-independent and HPV-related cervical adenocarcinoma
by: Jing He, et al.
Published: (2025-05-01)

Extraction-free RT-RPA assay for detection of HPV16, HPV18, and HPV45 mRNA expression
by: Emilie Newsham Novak, et al.
Published: (2025-08-01)

The diagnostic of PAX1 gene methylation in cervical lesions and its role in the triage of non-16/18 HR-HPV positive
by: Meng-Meng Chen, et al.
Published: (2025-07-01)

High prevalence of HPV16 and high‐grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2
by: Rikke Kamp Damgaard, et al.
Published: (2023-09-01)

Molecular Features of HPV-Independent Cervical Cancers
by: Luca Giannella, et al.
Published: (2025-07-01)

HPV infection and the immune microenvironment in cervical cancer
by: Yibo Li, et al.
Published: (2025-07-01)

Efficacy of HPV vaccine in preventing cervical cancer in the Tomsk region
by: O. A. Ananina, et al.
Published: (2023-06-01)

Genetic Association Between High‐Risk HPV (HPV16 and HPV18) Infection and Tumor Development: A Mendelian Randomization Analysis
by: You Wu, et al.
Published: (2025-04-01)

Application of vaginal self-sampling test combined with p16 protein detection in HPV shunt screening for cervical cancer in Hainan Province
by: MAI Yueshi, et al.
Published: (2024-12-01)

Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
by: Sarah Mafi, et al.
Published: (2025-01-01)

Southern Vietnamese women’s views on HPV vaccination, cervical cancer screening, and HPV self-sampling
by: Minh Tung Phung, et al.
Published: (2025-08-01)

Development of ZHPV16E7- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death
by: Xiaochun Tan, et al.
Published: (2025-07-01)

HPV transmission and optimal control of cervical cancer in China
by: Huarong Ren, et al.
Published: (2025-07-01)

Discontinuation of cervical cancer screening for HPV‐vaccinated women?
by: Jesper Bonde, et al.
Published: (2024-11-01)

HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
by: Emilia Włoszek, et al.
Published: (2025-02-01)

An amplicon-based approach for full-genome characterization of HPV16
by: Isabelle Malet, et al.
Published: (2025-07-01)

HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1
by: María de Lourdes Mora-García, et al.
Published: (2019-01-01)

HPV16 E7 inhibits HBD2 expression by down-regulation of ASK1-p38 MAPK pathway in cervical cancer
by: Juanjuan Liao, et al.
Published: (2025-04-01)

Down-regulation of miR-125b by HPV16 E6 might promote cervical cancer progression through TAZ/TEAD
by: Yongli Hou, et al.
Published: (2025-04-01)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.
by: Anna Godi, et al.
Published: (2015-01-01)

Evaluation of Anti-HPV18 Antibody Titers Preceding an Incident Cervical HPV18/45 Infection
by: Fanua Wiek, et al.
Published: (2025-07-01)

The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer
by: Márcia Poinho, et al.
Published: (2025-03-01)

MicroRNA, HPV AND CERVICAL CARCINOGENESIS: MOLECULAR ASPECTS AND PROSPECTS OF CLINICAL APPLICATION
by: P. A. Arkhangelskaya, et al.
Published: (2016-10-01)

High-Risk HPV Detection in Paraffin-Embedded Tissue from Cervical Lesions
by: Micaela Almeida, et al.
Published: (2024-09-01)

Exploring HPV-linked head and neck cancer in Southern Punjab, Pakistan: Insights from HPV-16 phylogenetic analysis
by: Muhammad Kashif, PhD, et al.
Published: (2025-04-01)